On Wednesday, in a significant development drugmaker Pfizer Inc said, all of its patented medicines including COVID-19 treatment Paxlovid and big-selling breast cancer drug Ibrance will be made available at not-for-profit prices to 45 of the world’s poorest countries. The bouquet… Read More ›
Treatment
COVID-19 pill by Japanese drug maker rapidly disarms SARS-CoV-2 virus
In a statement Japanese drug maker Shionogi & Co Ltd said, their experimental treatment for COVID-19 has shown rapid clearance of the virus that causes the disease. The pill, S-217622, “demonstrated rapid clearance of the infectious SARS-CoV-2 virus”, said Shionogi… Read More ›
AstraZeneca sold its 7.7% stake in Moderna Inc for more than $1 billion
According to a report from The Times, AstraZeneca Plc has sold its 7.7% stake in Moderna Inc for more than $1 billion. Moderna’s shares soared following news of its COVID-19 vaccine breakthrough. The report did not clarify the period over… Read More ›
PepsiCo rebrands ‘Aunt Jemima’ pancakes, syrup as Pearl Milling Company
In a statement PepsiCo Inc said, its pancake mix and syrup products will henceforth be sold under the “Pearl Milling Company” name; the development comes in the wake of the company dropping its “Aunt Jemima” brand logo in 2020 due… Read More ›
Teva Pharmaceutical Industries Ltd charged with price fixing of generic drugs: DoJ
The U.S. Justice Department has charged Teva Pharmaceutical Industries Ltd with charges including colluding to conspire with competitors to raise prices of widely used generic drugs, high cholesterol drug. “Today’s charge reaffirms that no company is too big to be… Read More ›
U.S. Commerce Department places Hikvision and other Chinese companies and public security bureaus on trade blacklist
The move will significantly impact the operations and earnings of dozens of Chinese companies including Megvii Technology Ltd, SenseTime Group Ltd and Chinese public security bureaus and sets the tone for U.S.-China trade negotiations.
AstraZeneca Plc and Daiichi Sankyo Co Ltd sign lucrative cancer drug deal
The deal sees Britain’s AstraZeneca Plc led by Pascal Soriot sharing development and commercialization costs for the drug worldwide. For AstraZeneca the deal makes sense as it will replenish its pipeline as its cancer drug sales grow. In a significant… Read More ›
Icahn boosts his stake in Bristol-Myers Squibb giving rise to takeover rumours
The company has added three new directors to its board, thus extending it to 14 directors. NY-based activist investor, JANA partners has boosted its stake in the company, although sources say it is less than 1%. In a move that… Read More ›
Electronic Smart Glasses Treat Children’s Amblyopia
New electronic smart glasses treat amblyopia in children in the similar manner as old scholl methods. U.S. has come up with trial results of its new “programmable electronic glasses” which is equally capable of improving vision impairment in children, which… Read More ›